In regard to Solomon et al.:: EGFR blockade with ZD1839 ("IRESSA") potentiates the antitumor effects of single and multiple fractions of ionizing radiation in human A431 squamous cell carcinoma.: IJROBP 2003;55:713-723

被引:5
作者
Krause, M [1 ]
Baumann, M
Thames, HD
机构
[1] Tech Univ Dresden, Clin Radiat Oncol, Med Fac Carl Gustav Carus, D-8027 Dresden, Germany
[2] Tech Univ Dresden, Clin Radiat Oncol & Expt Ctr, Med Fac Carl Gustav Carus, D-8027 Dresden, Germany
[3] Univ Texas, MD Anderson Canc Ctr, Dept Biomath, Houston, TX 77030 USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2003年 / 57卷 / 01期
关键词
D O I
10.1016/S0360-3016(03)00512-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:300 / 301
页数:2
相关论文
共 4 条
[1]  
BAUMANN M, IN PRESS INT J RAD B
[2]  
KALLMAN RF, 1987, RODENT TUMOR MODELS
[3]   EGFR blockade with ZD1839 ("Iressa") potentiates the antitumor effects of single and multiple fractions of ionizing radiation in human A431 squamous cell carcinoma [J].
Solomon, B ;
Hagekyriakou, J ;
Trivett, MK ;
Stacker, SA ;
McArthur, GA ;
Cullinane, C .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 55 (03) :713-723
[4]   ZD1839 ('Iressa'), a specific oral epidermal growth factor receptor-tyrosine kinase inhibitor, potentiates radiotherapy in a human colorectal cancer xenograft model [J].
Williams, KJ ;
Telfer, BA ;
Stratford, IJ ;
Wedge, SR .
BRITISH JOURNAL OF CANCER, 2002, 86 (07) :1157-1161